Stocklytics Platform
Asset logo for symbol PHVS
Pharvaris B.V.
PHVS52
$18.48arrow_drop_down2.77%-$0.53
Asset logo for symbol PHVS
PHVS52

$18.48

arrow_drop_down2.77%
Key Stats
Open$18.84
Prev. Close$19.07
EPS-2.75
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range18.48
19.27
52 Week Range15.00
33.00
Ratios
Revenue-
EBITDA Margin %-
EPS-2.75
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.72%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PHVS-
US Healthcare Sector-
US Market-
warning

PHVS / Market

PHVS lose to the US Market which returned -0.52% over the last twenty four hours.
warning

PHVS / Healthcare Sector

PHVS lose to the US Healthcare sector which returned 2.97% over the last twenty four hours.

Pharvaris B.V. (PHVS) Statistics

Pharvaris B.V. (PHVS) is a pharmaceutical company specializing in the development of innovative therapies for the treatment of hereditary angioedema (HAE) and other related disorders. As a leader in this field, Pharvaris is focused on bringing new, effective treatments to patients who suffer from these debilitating conditions. With a strong pipeline of promising drug candidates and a dedicated team of researchers and clinicians, Pharvaris is well-positioned to make a significant impact on the lives of HAE patients worldwide.
When it comes to valuation metrics, Pharvaris has shown promising results. The company's stock statistics reveal a steady growth in its market value, with the stock price experiencing positive trends. This is a positive indication of investor confidence in the company's potential and its ability to deliver value to shareholders. Additionally, Pharvaris' fundamentals are strong, with solid revenue growth and a healthy profit margin. These factors contribute to a positive perception of the company's overall financial health.
add Pharvaris B.V. to watchlist

Keep an eye on Pharvaris B.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Pharvaris B.V. (PHVS) stock's performance compared to its sector and the market over the past year?

Over the past year, Pharvaris B.V. (PHVS) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 30.94%, Pharvaris B.V. has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 60.46%, it has fallen short of the market average. This comparison highlights Pharvaris B.V.'s performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Pharvaris B.V. (PHVS) stock?

The PE ratio for Pharvaris B.V. (PHVS) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Pharvaris B.V. (PHVS) stock?

The Earnings Per Share (EPS) for Pharvaris B.V. (PHVS), calculated on a diluted basis, is -$2.75. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Pharvaris B.V. (PHVS) stock?

The operating margin for Pharvaris B.V. (PHVS) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Pharvaris B.V. (PHVS) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Pharvaris B.V. (PHVS) is -$122.7M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Pharvaris B.V. (PHVS) have?

Pharvaris B.V. (PHVS) has a total debt of $148.35K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$305.08M.

Take Your Investments to a Whole New Level